Partnership between Galen Data and Spark Biomedical strengthens their combined capability in support of connected medical devices and the ability to treat opioid withdrawal.

College Station, TX, May 3, 2019 — As Texas A&M New Ventures Competition 2019 #TNVC2019 approaches, May 15 – 17, the semi-finalist list has been announced. Spark Biomedical, Inc. is proud to be listed among the esteemed semi-finalists. Aimed at promoting the commercialization of emerging technology, the competition recognizes companies with high-growth potential and provides seed funding to help them effectively execute their ideas and advance product development.